⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19344 | 0.78 | — | — | |
| SCHEMBL13772887 | 0.78 | — | — | |
| SCHEMBL21301645 | 0.74 | — | — | |
| SCHEMBL12524755 | 0.72 | — | — | |
| SCHEMBL14258750 | 0.67 | — | — | |
| SCHEMBL13929019 | 0.66 | — | — | |
| SCHEMBL27921380 | 0.65 | — | — | |
| SCHEMBL22354655 | 0.65 | — | — | |
| SCHEMBL16614076 | 0.65 | — | — | |
| SCHEMBL13158542 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3307727-B1 | HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATMENT OF CANCER | ASANA BIOSCIENCES LLC (US) | 2023-10-04 | — | — | EP | disclosed |